InspireMD Other Operating Expenses from 2010 to 2025
| NSPR Stock | USD 2.44 0.07 2.79% |
Other Operating Expenses | First Reported 2009-03-31 | Previous Quarter 11.3 M | Current Value 13 M | Quarterly Volatility 2.8 M |
Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 194.1 K, Interest Expense of 23.9 K or Selling General Administrative of 8.6 M, as well as many indicators such as Price To Sales Ratio of 14.95, Dividend Yield of 0.0 or PTB Ratio of 3.21. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
InspireMD | Other Operating Expenses | Build AI portfolio with InspireMD Stock |
Latest InspireMD's Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of InspireMD over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of InspireMD. It is also known as InspireMD overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. InspireMD's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InspireMD's overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
InspireMD Other Operating Expenses Regression Statistics
| Arithmetic Mean | 19,981,777 | |
| Geometric Mean | 11,335,031 | |
| Coefficient Of Variation | 55.36 | |
| Mean Deviation | 8,339,146 | |
| Median | 19,946,000 | |
| Standard Deviation | 11,061,568 | |
| Sample Variance | 122.4T | |
| Range | 42.5M | |
| R-Value | 0.57 | |
| Mean Square Error | 88.8T | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 1,320,302 | |
| Total Sum of Squares | 1835.4T |
InspireMD Other Operating Expenses History
About InspireMD Financial Statements
InspireMD shareholders use historical fundamental indicators, such as Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although InspireMD investors may analyze each financial statement separately, they are all interrelated. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses on on InspireMD's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 40.5 M | 42.5 M |
Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.